ReproCELLorp (FRA:6RC) EV-to-FCF: (As of Jul. 04, 2026)


FRA:6RC ReproCELL Incorp FRA:6RC
57 GF Score
Price €0.49
GF Value €0.58
! 3 Warning Signs
View Full Analysis

What is ReproCELLorp EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ReproCELLorp's Enterprise Value is €33.48 Mil. ReproCELLorp's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil. Therefore, ReproCELLorp's EV-to-FCF for today is .

The historical rank and industry rank for ReproCELLorp's EV-to-FCF or its related term are showing as below:

FRA:6RC' s EV-to-FCF Range Over the Past 10 Years
Min: -11.58   Med: 0   Max: 0
Current: -11.58

FRA:6RC's EV-to-FCF is ranked worse than
100% of 332 companies
in the Biotechnology industry
Industry Median: 16.26 vs FRA:6RC: -11.58

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-04), ReproCELLorp's stock price is €0.494. ReproCELLorp's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.036. Therefore, ReproCELLorp's PE Ratio (TTM) for today is At Loss.


ReproCELLorp  (FRA:6RC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ReproCELLorp's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.494/-0.036
=At Loss

ReproCELLorp's share price for today is €0.494.
ReproCELLorp's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.036.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


ReproCELLorp EV-to-FCF Related Terms


ReproCELLorp EV-to-FCF Historical Data

* Premium members only.

The historical data trend for ReproCELLorp's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReproCELLorp EV-to-FCF Chart

ReproCELLorp Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.93 -46.86 -38.02 -111.03 -21.09

ReproCELLorp Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -111.03 0.00 0.00 0.00 -21.09

FRA:6RC vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, ReproCELLorp's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReproCELLorp EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReproCELLorp's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where ReproCELLorp's EV-to-FCF falls into.


FRA:6RC
57GF Score
ReproCELL Incorp FRA:6RC
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ReproCELLorp EV-to-FCF Calculation

ReproCELLorp's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=33.481/0
=

ReproCELLorp's current Enterprise Value is €33.48 Mil.
ReproCELLorp's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is ReproCELLorp (FRA:6RC) Overvalued in 2026?

Based on GuruFocus' analysis, ReproCELLorp stock appears to be undervalued. The current stock price of €0.49 is trading 14.8% below its estimated GF Value™ of €0.58.

Key valuation signals for FRA:6RC:

  • EV-to-FCF:
  • GF Value™: €0.58 vs. price of €0.49 (14.8% below fair value)
  • GF Score™: 57/100 with 3 warning signs

No single metric tells the full story. See the FRA:6RC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ReproCELLorp Business Description

Other Exchanges 4978:Japan
Address KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
57GF Score

Get the complete analysis for FRA:6RC

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.49
Price
€0.58
GF Value